Therapiekontrolle mittels serieller programmierter Ventrikelstimulation

  • A. Podczeck
  • W. Kaltenbrunner
  • K. Frohner
  • M. Nürnberg
  • K. Steinbach
Conference paper

Zusammenfassung

Wie bereits in Jahrzehnte zurückliegenden Untersuchungen beschrieben wurde, ist die Prognose von Patienten mit anhaltenden Tachyarrhythmien schlecht (2, 16, 26, 48). Die Mortalität dieses Kollektivs betrug über einen Beobachtungszeitraum von bis zu drei Jahren bis zu 60%. Durch Einsatz von Reanimationsteams im notärztlichen Dienst haben diese Patienten heute eine höhere Chance, die lebensbedrohlichen Arrhythmien akut zu überleben. Therapieziel bei ihnen ist es, das Wiederauftreten der potentiell letalen Tachyarrhythmie zu verhindern.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Adhar GC, Larson LW, Bardy GH, Greene HL (1988) Sustained ventricular arrhythmias: Differences between survivors of cardiac arrest and patients with recurrent sustained. JACC 12: 159–165PubMedGoogle Scholar
  2. 2.
    Armbrust CA, Levine SA (1950) Paroxysmal ventricular tachycardia: A study of one hundred and seven cases. Circulation 1: 28–40PubMedGoogle Scholar
  3. 3.
    Benditt DG, Benson DW, Klein GJ, Pritzker MR, Kriett JM, Anderson RW (1983) Prevention of recurrent sudden cardiac arrest: role of provocative electropharmacologic testing. JACC 2: 418–425PubMedGoogle Scholar
  4. 4.
    Borggrefe M, Trampisch H J, Breithardt G (1988) Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: Complete versus partial suppression of inducible arrhythmias. JACC 12: 140–149PubMedGoogle Scholar
  5. 5.
    Borggrefe, Podczeck A, Breithardt G (1986) Usefulness of early versus late electrophysiologic testing in patients with ventricular tachyarrhythmias treated with amiodarone (abstract). Circulation 74 (Suppl II): 11–223Google Scholar
  6. 6.
    Breithardt G, Seipel L, Abendroth RR, Loogen F (1980) Serial electrophysiological testing of antiarrhythmic drug efficacy in patients with recurrent ventricular tachycardia. Eur Heart J 1: 11–24PubMedGoogle Scholar
  7. 7.
    Breithardt G, Seipel L, Abendroth RR (1981) Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia. J Cardiovasc Pharmacol 3: 1026–1037PubMedCrossRefGoogle Scholar
  8. 8.
    Brugada P, Talajic M, Smeets J, Mulleneers R, Wellens HJJ (1989) The value of the clinical history to assess prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. Eur Heart J 10: 747–752PubMedGoogle Scholar
  9. 9.
    Buxton AE, Waxman HL, Marchlinski FE, Untereker WJ, Waspe LE, Josephson ME (1984) Role of triple extrastimuli during electrophysiologic study of patients with documented sustained ventricular tachyarrhythmias. Circulation 3: 532–540CrossRefGoogle Scholar
  10. 10.
    Cobb LA, Baum RS, Alvarez H, Schaffer WA (1975) Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up Circulation 51–52 (Suppl III): III-223-III-228Google Scholar
  11. 11.
    Connolly SJ, Kates RE, Lebsack CS, Echt DS, Mason JW, Winkle RA (1983) Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia. Am J Cardiol 52: 208–213CrossRefGoogle Scholar
  12. 12.
    Duff HJ, Mitchell LB, Bond R, Wyse DG (1983) Lack of reproducibility of inducible ventricular tachycardia over time (abstract). Circulation 68 (Suppl III): III–244CrossRefGoogle Scholar
  13. 13.
    Francis GS (1986) Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis. Am J Cardiol 57: 3B–7BPubMedCrossRefGoogle Scholar
  14. 14.
    Haffajee CI, Gold RL, Yazaki Y, Sloan K, Alpert JS (1986) Electrophysiologic predictors of long term outcome with amiodarone for refractory ventricular tachycardia (abstract). JACC 7: 109 AGoogle Scholar
  15. 15.
    Heger JJ, Hubbard J, Zipes DP, Miles WM, Prystowsky EN (1984) Propafenone treatment of recurrent ventricular tachycardia: comparison of continuous electrocardiographic recording and electrophysiologic study in predicting drug efficacy. Am J Cardiol 54: 40D–44DPubMedCrossRefGoogle Scholar
  16. 16.
    Herrmann GR, Park HM, Hejtmancik MR (1959) Paroxysmal ventricular tachycardia: a clinical and electrocardiographic study. Am Heart J 57: 166–176PubMedCrossRefGoogle Scholar
  17. 17.
    Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM (1978) Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.Google Scholar
  18. 18.
    Josephson ME, Horowitz LN, Farshidi A, Kastor JA (1978) Recurrent sustained ventricular tachycardia 1. Mechanisms. Circulation 57: 431–440PubMedGoogle Scholar
  19. 19.
    Kadish AH, Buxton AE, Waxman HL, Flores B, Josephson ME, Marchlinski FE (1987) Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy. JACC 10: 90–96PubMedGoogle Scholar
  20. 20.
    Kudenchuk PJ, Kron J, Walance CG, Murphy ES, Morris CD, Griffith KK, McAnulty JH (1986) Reproducibility of arrhythmia induction with intracardiac electrophysiologic testing: Patients with clinical sustained ventricular tachyarrhythmias. JACC 7: 819–828PubMedGoogle Scholar
  21. 21.
    Lai R, Chapman PD, Naccarrelli GV (1985) Short- and long-term experience with flecainide acetate in the management of refractory life-threatening ventricular arrhythmias. JACC 6: 772–779Google Scholar
  22. 22.
    Lavery D, Saksena S (1987) Management of refractory sustained ventricular tachycardia with amiodarone: A reappraisal. Am Heart J 113: 49–56PubMedCrossRefGoogle Scholar
  23. 23.
    Lerman BB, Waxman HL, Buxton AE, Josephson ME (1983) Disopyramide: Evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation. Am J Cardiol 51: 759–764Google Scholar
  24. 24.
    Liberthson RR, Nagel EL, Hirschmann JC, Nussenfeld SR (1974) Prehospital ventricular defibrillation. Prognosis and follow-up course. N Engl J Med 291: 317–321Google Scholar
  25. 25.
    Lombardi F, Stein J, Podrid PJ, Graboys TB, Lown B (1986) Daily reproducibility of electrophysiologic test results in malignant ventricular arrhythmia. Am J Cardiol 57: 96–101PubMedCrossRefGoogle Scholar
  26. 26.
    Lundy CJ, McLellan LL (1934) Paroxysmal ventricular tachycardia: an etiological study with special reference to the type. Ann Int Med 7: 812–836Google Scholar
  27. 27.
    Manz M, Steinbeck G, Nitsch J, Lüderitz B (1983) Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation. Br Heart J 49: 222–228Google Scholar
  28. 28.
    McPherson CA, Rosenfeld LE, Batsford WP (1985) Day-to-day reproducibility of responses to right ventricular programmed electrical stimulation: Implications for serial drug testing. Am J Cardiol 55: 689–695Google Scholar
  29. 29.
    Morady F, Scheinman MM, Hess DS, Sung RJ, Shen E, Shapiro W (1983) Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest. Am J Cardiol 51: 85–89PubMedCrossRefGoogle Scholar
  30. 30.
    Morady F, DiCarlo L, Winston S, Davis JC, Scheinman MM (1984) A prospective comparison of triple extrastimuli and left ventricular stimulation in studies of ventricular tachycardia induction. Circulation 70: 52–57PubMedCrossRefGoogle Scholar
  31. 31.
    Morady F, DiCarlo L, Winston S, Davis JC, Scheinman MM (1984) Clinical features and prognosis of patients with out of hospital cardiac arrest and a normal electrophysiologic study. JACC 4: 39–44PubMedGoogle Scholar
  32. 32.
    Nademanee K, Feld G, Hendrickson J, Singh PN, Singh BN (1985) Electrophysiologic and antiarrhythmic effects of Sotalol in patients with life-threatening ventricular tachyarrhythmias. Circulation 72: 555–564PubMedCrossRefGoogle Scholar
  33. 33.
    Podczeck A, Floren J, Borggrefe M, Breithardt G (1988) Beobachtungen zur klinischen Charakteristik von Patienten mit ventrikulären Tachyarrhythmien — 1978 bis 1986. Z Kardiol 7: 515–522Google Scholar
  34. 34.
    Podczeck A, Borggrefe M, Bartels K, Breithardt G (1989) Efficacy of flecainide in pacing-induced sustained ventricular tachyarrhythmias: correlation to clinical parameters and tachycardia-characteristics. Eur Heart J 10: 928–934PubMedGoogle Scholar
  35. 35.
    Podczeck A, Frohner K, Hief C, Stix G, Steinbach K (1991) Acute and long-term efficacy of propafenone in patients with sustained ventricular tachyarrhythmias: assessment with programmed ventricular stimulation. Eur Heart J, in pressGoogle Scholar
  36. 36.
    Rae AP, Greenspan AM, Spielman SR, Sokoloff NM, Webb CR, Kay HR, Horowitz LN (1985) Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies. Am J Cardiol 55: 1494–1499PubMedCrossRefGoogle Scholar
  37. 37.
    Roy D, Waxman HL, Kienzle MG, Buxton AE, Marchlinski FE, Josephson ME (1983) Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: Relation to inducibility at electrophysiologic testing. Am J Cardiol 52: 969–974Google Scholar
  38. 38.
    Schaffer WA, Cobb LA (1975) Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. N Engl J Med 293: 259–262PubMedCrossRefGoogle Scholar
  39. 39.
    Shen EN, Sung RJ, Morady F (1984) Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia. JACC 3: 1291–1297PubMedGoogle Scholar
  40. 40.
    Skale BT, Miles WM; Heger JJ, Zipes DP, Prystowsky (1986) Survivors of cardiac arrest: Prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring. Am J Cardiol 57: 113–119Google Scholar
  41. 41.
    Steinbeck G, Bach P, Haberl R (1986) Electrophysiologic and antiarrhythmic efficacy of oral Sotalol for sustained ventricular tachyarrhythmias: Evaluation by programmed stimulation and ambulatory electrocardiogram. JACC 8: 949–958Google Scholar
  42. 42.
    Surawicz B (1987) Prognosis of ventricular arrhythmias in relation to sudden cardiac death: therapeutic implications. JACC 10: 435–47PubMedGoogle Scholar
  43. 43.
    Swerdlow CD, Winkle RA, Mason JW (1983) Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med 308: 1426–1442CrossRefGoogle Scholar
  44. 44.
    Trappe HJ, Klein H, Lichtlen PR (1989) Antiarrhythmic efficacy of oral Sotalol in patients with sustained ventricular tachycardia of ventricular fibrillation postmyocardial infarction. J Electrophysiol 3: 95–100CrossRefGoogle Scholar
  45. 45.
    Waller TJ, Kay HR, Spielman SR, Kutalek SP, Greenspan AM, Horowitz LN (1987) Reduction in sudden death and total mortality by antiarrhythmic drug therapy evaluated by electrophysiologic drug testing: Criteria of efficacy in patients with sustained ventricular tachyarrhythmia. JACC 10: 83–89PubMedGoogle Scholar
  46. 46.
    Wilber DJ, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, Ruskin JN (1988) Out-ofhospital cardiac arrest. Use of lectrophysiologic testing in the prediction of long-term outcome. N Engl J Med 318: 19–24PubMedCrossRefGoogle Scholar
  47. 47.
    Willems AR, Tijssen JGP, van Capelle FJL, Kingma J, Hauer RNW, Vermeulen FEE, Brugada P, van Hoogenhuyze DCA, Janse MJ (1990) Determinants of prognosis in symptomatic ventricular tachycardia or ventricular fibrillation late after myocardial infarction. JACC 16: 521–530PubMedGoogle Scholar
  48. 48.
    Williams C, Ellis LB (1943) Ventricular tachycardia: an analysis of thirty-six cases. Arch Int Med 71: 137–156CrossRefGoogle Scholar
  49. 49.
    Zheutlin TA, Steinman RT, Mattioni TA, Kehoe RF (1988) Long-term arrhythmic outcome in survivors of ventricular fibrillation with absence of inducible ventricular tachycardia. Am J Cardiol 62: 1213–1217PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH Co. KG, Darmstadt 1991

Authors and Affiliations

  • A. Podczeck
    • 1
    • 2
  • W. Kaltenbrunner
    • 1
  • K. Frohner
    • 1
  • M. Nürnberg
    • 1
  • K. Steinbach
    • 1
  1. 1.Ludwig-Boltzmann-Institut für ArrhythmieforschungWilhelminenspitalWienAustria
  2. 2.III. Medizinische und Kardiologische AbteilungWilhelminen-SpitalWienGermany

Personalised recommendations